All stock lists
Scynexis Inc (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
Healthcare · Drug Manufacturers - Specialty & Generic
3.90+0.12 (+3.04%)
Insider Score
––Not scored
SCYX Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SCYX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 235.00 K | 0.00 | 18.65 M | 334.00 K | 1.36 M | — |
| Revenue Growth (YoY) | -82.77 % | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | 4.12 M | 4.59 M | 3.58 M | 3.29 M | 3.78 M | — |
| R&D Expense | 3.89 M | 12.35 M | 4.54 M | 5.45 M | 7.14 M | — |
| Operating Expenses | 8.01 M | 16.94 M | 8.13 M | 8.74 M | 10.93 M | — |
| Operating Income | -7.78 M | -16.94 M | 10.52 M | -8.40 M | -9.56 M | — |
| Pretax Income | 7.40 M | -21.30 M | 12.26 M | -8.59 M | -6.88 M | — |
| Tax Provision | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 7.40 M | -21.30 M | 12.26 M | -8.59 M | -6.88 M | — |
| EPS (Basic) | 0.63 | -3.36 | — | -1.36 | -1.11 | -0.88 |
| EPS (Diluted) | 0.63 | -3.36 | — | -1.36 | -1.11 | -0.88 |
| Shares Outstanding | 11.82 M | 6.37 M | — | 6.24 M | 6.22 M | 6.18 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.